NCT00046930
Clinical Trial Information
Trial Number: NCT00046930 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Leukemia - Acute Myeloid Leukemia
- Hematopoietic Neoplasm/Leukemia - Myelodysplastic Syndrome
Trial Title:
A Randomized, Placebo-Controlled, Double Blind, Trial of the Administration of the MDR Modulator, Zosuquidar Trihydrochloride (LY335979), During Conventional Induction and Post-Remission Therapy in Patients Greater Than 60 Years of Age With Newly Diagnosed Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation or High-Risk Refractory Anemia With Excess Blasts
Study ID:
E3999
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00046930-D4 | There are four different submissions (each for 227 patients) for PMID 37407550 (a correction for PMID 36151075) from the trial E3999. This dataset, NCT00046930-D4, contains the second set of mutation data. Dataset NCT00046930-D1, contains baseline, treatment, and efficacy data. Dataset NCT00046930-D2 contains cytogenetic data. Dataset NCT00046930-D3 contains the first set of mutation data. |
| NCT00046930-D3 | There are four different submissions (each for 227 patients) for PMID 37407550 (a correction for PMID 36151075) from the trial E3999. This dataset, NCT00046930-D3, contains the first set of mutation data. Dataset NCT00046930-D1, contains baseline, treatment, and efficacy data. Dataset NCT00046930-D2 contains cytogenetic data. Dataset NCT00046930-D4 contains the second set of mutation data. |
| NCT00046930-D2 | There are four different submissions (each for 227 patients) for PMID 37407550 (a correction for PMID 36151075) from the trial E3999. This dataset, NCT00046930-D2, contains cytogenetic data. Dataset NCT00046930-D1 contains baseline, treatment, and efficacy. Dataset NCT00046930-D3 contains the first set of mutation data. Dataset NCT00046930-D4 contains the second set of mutation data. |
| NCT00046930-D1 | There are four different submissions (each for 227 patients) for PMID 37407550 (a correction for PMID 36151075) from the trial E3999. This dataset, NCT00046930-D1, contains baseline, treatment, and efficacy data. Dataset NCT00046930-D2 contains cytogenetic data. Dataset NCT00046930-D3 contains the first set of mutation data. Dataset NCT00046930-D4 contains the second set of mutation data. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®